Allscripts Healthcare Solutions Company Profile (NASDAQ:MDRX)

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions logoAllscripts Healthcare Solutions, Inc. delivers information technology (IT) and services to help healthcare organizations in clinical, financial and operational results. The Company operates through two segments: Clinical and Financial Solutions, and Population Health. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions, which primarily include electronic health record (EHR)-related software, financial and practice management software, related installation, support and maintenance, outsourcing, hosting, revenue cycle management, training and electronic claims administration services. Its Population Health segment includes sale of health management and coordinated care solutions that are focused on hospitals, health systems, other care facilities and accountable care organizations. These solutions enable clients to connect, transition, analyze, and coordinate care across the care community.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Application Software
  • Sub-Industry: Health Care Technology
  • Exchange: NASDAQ
  • Symbol: MDRX
  • CUSIP: 01988P10
Key Metrics:
  • Previous Close: $12.39
  • 50 Day Moving Average: $11.52
  • 200 Day Moving Average: $12.00
  • 52-Week Range: $183,199,000.00 - $9.80
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 17.21
  • P/E Growth: 1.39
  • Market Cap: $2.27B
  • Outstanding Shares: 183,199,000
  • Beta: 1.31
Profitability:
  • Net Margins: -0.14%
  • Return on Equity: 5.79%
  • Return on Assets: 2.50%
Debt:
  • Debt-to-Equity Ratio: 0.88%
  • Current Ratio: 0.94%
  • Quick Ratio: 0.94%
Additional Links:
Companies Related to Allscripts Healthcare Solutions:

Analyst Ratings

Consensus Ratings for Allscripts Healthcare Solutions (NASDAQ:MDRX) (?)
Ratings Breakdown: 1 Sell Rating, 9 Hold Ratings, 9 Buy Ratings
Consensus Rating:Hold (Score: 2.42)
Consensus Price Target: $14.75 (19.05% upside)

Analysts' Ratings History for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Show:
DateFirmActionRatingPrice TargetDetails
2/17/2017Oppenheimer Holdings, Inc.Reiterated RatingHoldView Rating Details
2/17/2017Jefferies Group LLCReiterated RatingBuyView Rating Details
2/17/2017Cantor FitzgeraldBoost Price TargetIn-Line$12.00 -> $13.00View Rating Details
2/13/2017Dougherty & CoUpgradeNeutral -> Buy$15.00View Rating Details
1/31/2017Deutsche Bank AGDowngradeBuy -> HoldView Rating Details
1/10/2017Maxim GroupLower Price TargetBuy$18.00 -> $16.00View Rating Details
1/8/2017FBR & CoReiterated RatingHold$12.00View Rating Details
1/3/2017Canaccord GenuityReiterated RatingBuy$17.00View Rating Details
12/13/2016Morgan StanleyDowngradeEqual Weight -> Underweight$15.00 -> $10.00View Rating Details
10/30/2016J P Morgan Chase & CoInitiated CoverageBuy$15.00View Rating Details
10/23/2016ArgusReiterated RatingBuy$19.00View Rating Details
9/23/2016Leerink SwannReiterated RatingOutperform$17.00View Rating Details
9/8/2016Cowen and CompanyDowngradeOutperform -> Market Perform$17.00 -> $14.00View Rating Details
8/8/2016Piper Jaffray CompaniesReiterated RatingNeutral$12.00 -> $15.00View Rating Details
8/5/2016Goldman Sachs Group, Inc. (The)Boost Price TargetNeutral$14.00 -> $16.00View Rating Details
7/9/2016Robert W. BairdReiterated RatingBuyView Rating Details
5/22/2016KeyCorpReiterated RatingHoldView Rating Details
5/13/2016Citigroup Inc.Boost Price TargetNeutral$13.00 -> $14.00View Rating Details
2/24/2016SunTrust Banks, Inc.Lower Price TargetBuy$18.00 -> $15.00View Rating Details
2/19/2016Barclays PLCLower Price TargetEqual Weight$15.00 -> $14.00View Rating Details
2/19/2016Royal Bank Of CanadaReiterated RatingOutperform$19.00 -> $17.00View Rating Details
1/5/2016Topeka Capital MarketsBoost Price TargetHold$14.00 -> $15.00View Rating Details
1/4/2016Raymond James Financial, Inc.DowngradeOutperform -> Market PerformView Rating Details
11/6/2015Evercore ISIBoost Price TargetHold$14.00 -> $15.00View Rating Details
10/21/2015Avondale PartnersInitiated CoverageOutperform$19.00View Rating Details
5/23/2015Credit Suisse GroupReiterated RatingOutperform$15.00 -> $16.00View Rating Details
4/6/2015Stifel NicolausInitiated CoverageHoldView Rating Details
(Data available from 2/20/2015 forward)

Earnings

Earnings History for Allscripts Healthcare Solutions (NASDAQ:MDRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2017        
2/16/2017Q4 2016$0.15$0.14$424.11 million$425.40 millionViewListenView Earnings Details
11/3/2016Q3$0.15$0.14$414.92 million$392.40 millionViewListenView Earnings Details
8/4/2016Q2$0.14$0.14$403.13 million$386.50 millionViewListenView Earnings Details
5/5/2016Q1$0.12$0.13$348.51 million$346.00 millionViewListenView Earnings Details
2/18/2016Q4$0.13$0.13$357.91 million$345.60 millionViewListenView Earnings Details
11/5/2015Q315$0.12$0.13$354.67 million$355.00 millionViewListenView Earnings Details
8/4/2015Q215$0.11$0.12$347.13 million$351.70 millionViewListenView Earnings Details
5/7/2015Q115$0.09$0.08$344.73 million$335.00 millionViewListenView Earnings Details
2/26/2015Q414$0.09$0.09$358.10 million$343.00 millionViewListenView Earnings Details
11/6/2014Q314$0.10$0.06$353.00 million$348.00 millionViewListenView Earnings Details
8/7/2014Q214$0.09$0.09$353.12 million$351.30 millionViewListenView Earnings Details
5/8/2014Q114$1.01$0.07$347.98 billion$340.30 billionViewListenView Earnings Details
2/20/2014Q413$0.08$0.08$343.47 million$351.00 millionViewListenView Earnings Details
11/7/2013Q313$0.08$0.05$355.30 million$334.00 millionViewListenView Earnings Details
8/8/2013Q2 2013$0.11$0.09$360.00 million$344.80 millionViewListenView Earnings Details
5/9/2013Q1 2013$0.14$0.09$368.11 million$347.10 millionViewListenView Earnings Details
2/19/2013Q4 2012$0.21$0.16$367.07 million$367.70 millionViewListenView Earnings Details
11/8/2012Q312$0.22$0.23$376.97 million$361.00 millionViewN/AView Earnings Details
8/8/2012$0.18$0.16ViewN/AView Earnings Details
4/26/2012$0.24$0.12ViewN/AView Earnings Details
2/16/2012$0.25$0.25ViewN/AView Earnings Details
11/3/2011$0.22$0.25ViewN/AView Earnings Details
8/2/2011$0.21$0.22ViewN/AView Earnings Details
5/5/2011$0.20$0.21ViewN/AView Earnings Details
2/15/2011$0.18$0.20ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Current Year EPS Consensus Estimate: $0.65 EPS
Next Year EPS Consensus Estimate: $0.72 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.08$0.08$0.08
Q2 20162$0.09$0.10$0.10
Q3 20162$0.10$0.12$0.11
Q4 20165$0.12$0.14$0.13
Q1 20172$0.11$0.12$0.12
Q2 20172$0.12$0.12$0.12
Q3 20172$0.12$0.12$0.12
Q4 20171$0.12$0.12$0.12
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Allscripts Healthcare Solutions (NASDAQ:MDRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Insider Ownership Percentage: 0.75%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/15/2016James HewittSVPSell17,500$13.00$227,500.00View SEC Filing  
9/15/2016Paul BlackCEOSell15,000$13.00$195,000.00View SEC Filing  
7/11/2016Dennis OlisSVPSell7,000$14.00$98,000.00View SEC Filing  
7/1/2016James HewittSVPSell17,500$13.00$227,500.00View SEC Filing  
6/13/2016Paul BlackCEOSell15,000$13.04$195,600.00View SEC Filing  
6/13/2016Richard J PoultonPresidentSell10,000$13.03$130,300.00View SEC Filing  
4/7/2016Dennis OlisSVPSell25,000$14.00$350,000.00View SEC Filing  
3/30/2016James HewittSVPSell17,500$13.31$232,925.00View SEC Filing  
3/30/2016Paul BlackCEOSell15,000$13.31$199,650.00View SEC Filing  
3/14/2016Richard J PoultonPresidentSell5,000$12.85$64,250.00View SEC Filing  
8/17/2015James HewittSVPSell70,000$14.17$991,900.00View SEC Filing  
12/12/2014Paul BlackCEOBuy6,500$11.51$74,815.00View SEC Filing  
11/18/2014Anita PramodaDirectorBuy2,017$12.25$24,708.25View SEC Filing  
11/13/2014Dennis ChookaszianDirectorBuy10,000$12.43$124,300.00View SEC Filing  
11/11/2014Dennis OlisSVPBuy4,400$11.26$49,544.00View SEC Filing  
11/11/2014Paul BlackCEOBuy22,180$11.26$249,746.80View SEC Filing  
11/11/2014Richard J PoultonCFOBuy4,500$11.26$50,670.00View SEC Filing  
11/11/2014Stuart L BascombDirectorBuy6,743$11.26$75,926.18View SEC Filing  
8/18/2014Michael KlaykoDirectorBuy3,500$14.41$50,435.00View SEC Filing  
3/13/2014Deborah SnowSVPSell14,740$18.75$276,375.00View SEC Filing  
11/21/2013Deborah SnowSVPSell2,400$14.70$35,280.00View SEC Filing  
9/9/2013Clifford B MeltzerEVPSell35,000$14.56$509,600.00View SEC Filing  
8/15/2013Michael KlaykoDirectorBuy10,000$14.80$148,000.00View SEC Filing  
5/30/2013Deborah SnowSVPSell1,495$13.71$20,496.45View SEC Filing  
5/20/2013Stuart L BascombDirectorBuy3,701$14.02$51,888.02View SEC Filing  
5/15/2013Paul BlackCEOBuy7,120$14.02$99,822.40View SEC Filing  
5/14/2013Steve ShuteVPSell14,612$14.10$206,029.20View SEC Filing  
3/12/2013Paul BlackCEOBuy23,625$12.69$299,801.25View SEC Filing  
3/12/2013Stuart L BascombDirectorBuy10,000$12.64$126,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Allscripts Healthcare Solutions (NASDAQ:MDRX)
DateHeadline
News IconWill Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) beat earning estimates again? (NASDAQ:MDRX)
hypelee.com - February 17 at 7:53 PM
News IconAllscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Earns 13 Analysts Hold Rating (NASDAQ:MDRX)
nyhetsbanken.info - February 17 at 7:53 PM
News IconTrading Update on Shares of Allscripts Healthcare Solutions Inc. (MDRX) - Baldwin Journal (NASDAQ:MDRX)
baldwinjournal.com - February 17 at 2:52 PM
streetinsider.com logoAllscripts (MDRX) PT Raised to $13 at Cantor Fitzgerald Following ... - StreetInsider.com (NASDAQ:MDRX)
www.streetinsider.com - February 17 at 2:52 PM
seekingalpha.com logoAllscripts Healthcare Solutions (MDRX) Q4 2016 Results - Earnings Call Transcript - Seeking Alpha (NASDAQ:MDRX)
seekingalpha.com - February 17 at 2:52 PM
marketexclusive.com logoALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (NASDAQ:MDRX) Files An 8-K Results of Operations and Financial ... - Market Exclusive (NASDAQ:MDRX)
marketexclusive.com - February 17 at 2:52 PM
finance.yahoo.com logoEdited Transcript of MDRX earnings conference call or presentation 16-Feb-17 9:30pm GMT (NASDAQ:MDRX)
finance.yahoo.com - February 17 at 2:52 PM
finance.yahoo.com logoAllscripts (MDRX) Q4 Earnings Miss Estimates, View Upbeat (NASDAQ:MDRX)
finance.yahoo.com - February 17 at 2:52 PM
News IconImpact of Brokerage Rating on Allscripts Healthcare Solutions, Inc.(MDRX) (NASDAQ:MDRX)
www.graffiotech.com - February 16 at 6:05 PM
News IconAllscripts Healthcare Solutions Inc (NASDAQ:MDRX)
mundoaguaysaneamiento.net - February 16 at 6:05 PM
nasdaq.com logoAllscripts Healthcare Posts Q4 Loss - Update (NASDAQ:MDRX)
www.nasdaq.com - February 16 at 6:05 PM
News IconCan Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Show Upward Trend after Earnings? (NASDAQ:MDRX)
prensariotiretail.com - February 16 at 6:05 PM
rttnews.com logoAllscripts Healthcare Solutions Inc. Reports 4% Rise In Q4 Earnings (NASDAQ:MDRX)
www.rttnews.com - February 16 at 6:05 PM
biz.yahoo.com logoQ4 2016 Allscripts Healthcare Solutions Inc Earnings Release - After Market Close (NASDAQ:MDRX)
us.rd.yahoo.com - February 16 at 6:05 PM
us.rd.yahoo.com logoAllscripts announces fourth quarter and 2016 full-year results (NASDAQ:MDRX)
us.rd.yahoo.com - February 16 at 6:05 PM
biz.yahoo.com logoALLSCRIPTS HEALTHCARE SOLUTIONS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial St (NASDAQ:MDRX)
us.rd.yahoo.com - February 16 at 6:05 PM
us.rd.yahoo.com logo4:07 pm Allscripts Healthcare misses by $0.01, beats on revs; reaffirms FY17 EPS guidance, revs guidance (NASDAQ:MDRX)
us.rd.yahoo.com - February 16 at 6:05 PM
wsj.com logo[$$] Allscripts Revenue Rises on Netsmart Acquisition (NASDAQ:MDRX)
us.rd.yahoo.com - February 16 at 6:05 PM
sg.finance.yahoo.com logoAllScripts reports 4Q loss (NASDAQ:MDRX)
sg.finance.yahoo.com - February 16 at 6:05 PM
nasdaq.com logoMDRX Makes Bullish Cross Above Critical Moving Average (NASDAQ:MDRX)
www.nasdaq.com - February 15 at 1:03 AM
News IconTracking the Numbers for Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) - Davidson Register (NASDAQ:MDRX)
davidsonregister.com - February 14 at 5:41 AM
realistinvestor.com logoAllscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Is Expected To Post EPS Of $0.17 (NASDAQ:MDRX)
www.realistinvestor.com - February 12 at 6:18 PM
istreetwire.com logoStocks Highlights: Allscripts Healthcare Solutions, Inc. (MDRX), Vonage Holdings Corp. (VG), Community Health ... - iStreetWire (NASDAQ:MDRX)
istreetwire.com - February 11 at 12:21 AM
nasdaq.com logoCan Allscripts (MDRX) Surprise Investors in Q4 Earnings? - Nasdaq (NASDAQ:MDRX)
www.nasdaq.com - February 11 at 12:21 AM
News IconWatching the Levels on Shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) - The Standard (NASDAQ:MDRX)
6milestandard.com - February 8 at 12:49 AM
marketwatch.com logoChicago health-care and insurance entrepreneur: Obamacare overhaul more likely to be ‘rename and reface’ (NASDAQ:MDRX)
us.rd.yahoo.com - February 7 at 7:47 PM
marketwatch.com logoTullman: Obamacare overhaul more likely to be ‘rename and reface’ (NASDAQ:MDRX)
www.marketwatch.com - February 6 at 6:34 PM
News IconEarnings Forecast Research on Allscripts Healthcare Solutions, Inc. (MDRX) (NASDAQ:MDRX)
flapship.com - February 1 at 7:21 PM
finance.yahoo.com logoBlack Book Rankings™ names Allscripts top core EHR with a population health management solution (NASDAQ:MDRX)
finance.yahoo.com - February 1 at 7:21 PM
News IconEarnings Forecast Research on Allscripts Healthcare Solutions, Inc. (MDRX) - Highland Mirror (NASDAQ:MDRX)
www.highlandmirror.com - February 1 at 6:33 AM
News IconGray Financial Group Ga Adv Adv Boosts Position by $290984 in Allscripts Healthcare Solutions Inc (MDRX) - Highland Mirror (NASDAQ:MDRX)
www.highlandmirror.com - January 31 at 7:23 PM
finance.yahoo.com logoAllscripts open ecosystem enables more than 2 billion data shares, continues to lead industry in innovation, data sharing and connectivity (NASDAQ:MDRX)
finance.yahoo.com - January 30 at 9:53 AM
News IconWhat are Stock Advisors saying about Allscripts Healthcare Solutions, Inc. (MDRX) (NASDAQ:MDRX)
flapship.com - January 29 at 6:53 PM
News IconChart Watch: Checking on Shares of Allscripts Healthcare Solutions Inc. (MDRX) - Sherwood Daily (NASDAQ:MDRX)
sherwooddaily.com - January 28 at 11:37 PM
News IconEarnings in Full Force, Analysts Take Aim at Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) - Wall Street Beacon (NASDAQ:MDRX)
wsbeacon.com - January 25 at 7:56 PM
News IconEarnings Take Center Stage; Analysts Weighing in on Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) - Aiken Advocate (NASDAQ:MDRX)
aikenadvocate.com - January 23 at 6:46 PM
News IconAnalysts Pounding The Pavement on Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX): Consensus Update - Wall Street Beacon (NASDAQ:MDRX)
wsbeacon.com - January 23 at 6:46 PM
realistinvestor.com logoQuarterly Deferred Tax Assets Of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) At $35.736 Millions - RealistInvestor.com (NASDAQ:MDRX)
www.realistinvestor.com - January 22 at 6:17 PM
News IconTechnical Review on Shares of Allscripts Healthcare Solutions Inc. (MDRX) - Springdale Times (NASDAQ:MDRX)
springdaletimes.com - January 22 at 6:17 PM
News IconThe Case for and Against Allscripts Healthcare Solutions, Inc. (MDRX) - StockNewsJournal (NASDAQ:MDRX)
stocknewsjournal.com - January 20 at 7:17 PM
News IconDevling Into Shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX), What Are Analysts Predicting for 2017? - Wall Street Beacon (NASDAQ:MDRX)
wsbeacon.com - January 19 at 8:30 PM
finance.yahoo.com logoAllscripts expands leadership team; heightening focus on client support, international growth (NASDAQ:MDRX)
finance.yahoo.com - January 19 at 8:30 PM
capitalcube.com logoETFs with exposure to Allscripts Healthcare Solutions, Inc. : January 19, 2017 (NASDAQ:MDRX)
www.capitalcube.com - January 19 at 8:30 PM
News IconWhat is the Street Saying About Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)? - Aiken Advocate (NASDAQ:MDRX)
aikenadvocate.com - January 17 at 11:52 AM
News IconWall Street and Armchair Analysts Weigh in on Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Heading Into The ... - Wall Street Beacon (NASDAQ:MDRX)
wsbeacon.com - January 17 at 11:52 AM
realistinvestor.com logoAllscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) EPS Estimate At $0.17 - RealistInvestor.com (NASDAQ:MDRX)
www.realistinvestor.com - January 16 at 8:09 AM
News IconAllscripts Healthcare Solutions Inc 37.9% Potential Upside Now Implied by Maxim Group (NASDAQ:MDRX)
onemma.net - January 12 at 7:02 PM
seekingalpha.com logoAllscripts Healthcare Solutions (MDRX) presents at 35th Annual J.P. Morgan Healthcare Conference (NASDAQ:MDRX)
seekingalpha.com - January 12 at 12:05 AM
News IconCompany Spotlight on Shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) - Wall Street Beacon (NASDAQ:MDRX)
wsbeacon.com - January 11 at 7:03 PM
barrons.com logo[$$] Allscripts: Curb Your Enthusiasm (NASDAQ:MDRX)
www.barrons.com - January 11 at 7:03 PM

Social

What is Allscripts Healthcare Solutions' stock symbol?

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

Where is Allscripts Healthcare Solutions' stock going? Where will Allscripts Healthcare Solutions' stock price be in 2017?

19 brokerages have issued 1-year target prices for Allscripts Healthcare Solutions' shares. Their forecasts range from $10.00 to $19.00. On average, they anticipate Allscripts Healthcare Solutions' stock price to reach $14.75 in the next twelve months.

When will Allscripts Healthcare Solutions announce their earnings?

Allscripts Healthcare Solutions is scheduled to release their next quarterly earnings announcement on Wednesday, May, 3rd 2017.

What are analysts saying about Allscripts Healthcare Solutions stock?

Here are some recent quotes from research analysts about Allscripts Healthcare Solutions stock:

  • Jefferies Group LLC analysts commented, "Key to the EBITDA/EPS growth story is consolidated organic revenue growth (and resulting fixed cost leverage), and MDRX achieved that for the first time in several quarters. Looking forward, mgmt believes the "bulk" of the non-recurring revenue declines is now behind them, meaning the benefits of the business model shift should now become more visible. Bookings set an impressive record during 4Q, increasing our confidence in continued recurring revenue growth." (2/17/2017)
  • Cantor Fitzgerald analysts commented, "We reiterate our Neutral rating on Allscripts shares, but we raise our 12-month target price slightly to $13 from $12. After the close on Thursday, February 16, the company reported 4Q16 results that were essentially in line with our estimates. 2017 guidance is similar to its initial outlook, which it provided in early January. Revenue is expected to be $1.71-1.74 billion, which implies about 9.5% growth. Core Allscripts should grow in the mid- to high-single-digit range. Adjusted EPS is expected to grow 10-15% from 2016 levels. Our adjusted EPS estimate remains unchanged at $0.62 compared to FactSet consensus of $0.65. We believe the shares already reflect a modest improvement in growth rates in subsequent years. Accordingly, our rating remains at Neutral." (2/17/2017)
  • According to Zacks Investment Research, "Over the past three months, Allscripts has outperformed the broader industry trend in terms of price movement. However, an unfavorable estimate revision trend indicates looming concerns aheadof the stock. An intensifying market competition is a major dampener for Allscripts as large companies like Cerner, compete against Allscripts with a far simpler rationale for their products. Additionally, the Optum partnership is expected to have a cost-heavy impact on the revenues. Allscripts’ products have a long sales cycle which involves decision-making at different managerial levels. On a positive note, Allscripts has been reporting regular contract wins and addition of new domestic and international clients, which is expected to boost bookings in the coming quarters. Furthermore, the growing adoption of Allscripts’ products and services like the Sunrise platform, FollowMyHealth, Touchworks EHR, EPSi and dbMotion will drive market traction." (1/12/2017)

  • Leerink Swann analysts commented, "strategic alignment, innovation, client relationships and customization."Leerink's channel checks also provided a favorable view. Bookings have witnessed consistent year-over-year growth in the six past quarters.Related Link: Pfizer Has Had A Busy M&A Year...Or Has It?The brokerage said, "We expect adjusted EPS to grow by over 20 percent y/y in 2016E and 2017E, and we believe that MDRX is becoming a more attractive acquisition candidate. In our view the recent deal with Optum shows that the quality of the product and longer-term vision of MDRX have improved substantially over the past few years. Upgrade to Outperform, PT to $17 (from $16)." (8/23/2016)

Who owns Allscripts Healthcare Solutions stock?

Allscripts Healthcare Solutions' stock is owned by many different of retail and institutional investors. Top institutional investors include Iridian Asset Management LLC CT (7.17%), Glenhill Advisors LLC (4.14%), Dimensional Fund Advisors LP (3.57%), State Street Corp (2.55%), Fiduciary Management Inc. WI (2.54%) and Royce & Associates LP (1.00%). Company insiders that own Allscripts Healthcare Solutions stock include Dennis Olis, James Hewitt, Paul Black and Richard J Poulton.

Who sold Allscripts Healthcare Solutions stock? Who is selling Allscripts Healthcare Solutions stock?

Allscripts Healthcare Solutions' stock was sold by a variety of institutional investors in the last quarter, including Glenhill Advisors LLC, Oxford Asset Management, AQR Capital Management LLC, Systematic Financial Management LP, Ancora Advisors LLC, State Street Corp, Pacad Investment Ltd. and Cipher Capital LP. Company insiders that have sold Allscripts Healthcare Solutions stock in the last year include Dennis Olis, James Hewitt, Paul Black and Richard J Poulton.

Who bought Allscripts Healthcare Solutions stock? Who is buying Allscripts Healthcare Solutions stock?

Allscripts Healthcare Solutions' stock was bought by a variety of institutional investors in the last quarter, including Iridian Asset Management LLC CT, Fiduciary Management Inc. WI, Russell Investments Group Ltd., Dimensional Fund Advisors LP, Cortina Asset Management LLC, Two Sigma Investments LP, Royce & Associates LP and A.R.T. Advisors LLC.

How do I buy Allscripts Healthcare Solutions stock?

Shares of Allscripts Healthcare Solutions can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Allscripts Healthcare Solutions stock cost?

One share of Allscripts Healthcare Solutions stock can currently be purchased for approximately $12.39.

Allscripts Healthcare Solutions (NASDAQ:MDRX) Chart for Monday, February, 20, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Earnings History Chart

Earnings by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Dividend History Chart

Dividend Payments by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Last Updated on 2/20/2017 by MarketBeat.com Staff